Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03446079 · ClinicalTrials.gov registry record · NA
Relationship of Skin Related SNP to Topical Skin Care Product
A NA study of Skin Aging and Genetics, sponsored by HelicalCodeMD.
- Completed
- Registry status
- NA
- Development phase
- 156
- Enrollment target
- 1
- Study location
NCT03446079: Completed NA study of Skin Aging and Genetics, sponsored by HelicalCodeMD.
NCT03446079 is a NA study of Skin Aging and Genetics that has completed, run by HelicalCodeMD. The registered enrollment target is 156 participants, above the 58-participant average among 9 other Skin Aging trials with a reported enrollment target (169% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03446079, a NA study of Skin Aging and Genetics, has completed, sponsored by HelicalCodeMD.
- COMPLETED
- Registry status
- NA
- Development phase
- 156 participants
- Enrollment target
- 1
- Study location
Study Summary
Demonstrate the relationship between single nucleotide polymorphisms (SNP) and response to a topical skin care product.
Primary Outcome
The primary endpoint being studied in this study is the association of the product response to the 17 candidate SNP genotypes.
Conditions Studied
Interventions
- OTHER Topical Anti Aging Cream
Study Locations (1)
California
- Halcyon Dermatology - Laguna Hills
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 156 participants |
| Start Date | 2018-03-19 |
| Est. Completion | 2022-12-28 |
| Phase | NA |
What the finished NCT03446079 record still lists
NCT03446079 is an interventional study that assigns participants to a tested intervention. The registered 156 participants enrollment target is mid-sized for trials with a published cap, above the 58-participant average among 9 other Skin Aging trials with a reported enrollment target (169% higher).
The record links to 2 conditions, with Skin Aging appearing as the primary indexed condition, and to 1 intervention - of which Topical Anti Aging Cream is the first listed.
NCT03446079 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT03446079 about?
NCT03446079 is a clinical study titled "Relationship of Skin Related SNP to Topical Skin Care Product". Demonstrate the relationship between single nucleotide polymorphisms (SNP) and response to a topical skin care product.
What is the current status of trial NCT03446079?
This trial is currently completed. It is a NA study. The enrollment target is 156 participants. The study started on 2018-03-19. Estimated completion is 2022-12-28.
What conditions does trial NCT03446079 study?
This clinical trial studies the following conditions: Skin Aging, Genetics.
What interventions are being tested in trial NCT03446079?
The interventions under investigation include: Topical Anti Aging Cream (OTHER).
Who is sponsoring clinical trial NCT03446079?
This trial is sponsored by HelicalCodeMD, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03446079 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Skin Aging
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03446079's enrollment target sits among peer trials
156 2nd of 9 the highest of 9 other Skin Aging trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Skin Aging trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Clinical Study to Evaluate the Efficacy of Activated Silk™ 27P-α in Subjects, Aged 35-65 Years of Age, to Improve the Signs of Aging
ACTIVE NOT RECRUITING · NA
-
A Clinical Study to Evaluate the Efficacy of Activated Silk™ 27P-α in Subjects, Aged 35-65 Years of Age, to Improve the Signs of Aging, by Comparing to a Placebo
ACTIVE NOT RECRUITING · NA
-
Clinical Trial to Evaluate the Efficacy of Skin Products to Improve Skin Quality and Health
COMPLETED · NA
-
Thermage CPT for Treatment of Facial and Neck Laxity
COMPLETED · NA
-
A Proof of Concept Study to Evaluate the Efficacy and Tolerability of Skinpen on Male and Female Subjects' Dorsal Hands as a Treatment of Hand Aging
COMPLETED · NA
-
Efficacy of a Dietary Supplement on Parameters of Skin Aging in Men and Women
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03082755 · 156 participants · Phase 4
Nighttime Agitation and Restless Legs Syndrome in People With Alzheimer's Disease
- NCT04047628 · 156 participants · Phase 3
Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)
- NCT04166877 · 156 participants · Phase 4
Magnesium Infusion for Pain Management in Critically Ill Trauma Patients
- NCT04533464 · 156 participants · Phase 2
MultiStem® for Treatment of Trauma Induced Multiple Organ Failure/Systemic Inflammatory Response Syndrome
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI